Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Abstract Adenoviral vectors have been explored as vaccine agents for a range of infectious diseases, and their ability to induce a potent and balanced immune response made them logical candidates to apply to the COVID-19 pandemic. The unique molecular characteristics of these vectors enabled the rap...
Guardado en:
Autores principales: | Samir Andrade Mendonça, Reka Lorincz, Paul Boucher, David T. Curiel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2884d62b3ff9428ba246fbb13c87a66c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Viral vector-based vaccines against SARS-CoV-2
por: Kenneth Lundstrom
Publicado: (2021) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
por: L. V. Cherenova, et al.
Publicado: (2017) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
por: L. V. Cherenova, et al.
Publicado: (2017) -
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
por: Charles Yap, et al.
Publicado: (2021) -
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
por: Clement A. Meseda, et al.
Publicado: (2021)